BLUE ISLAND PLC financials
BLUE ISLAND PLC
2138003DUDZ8R67LEO26 | Line item | 2021 | 2020 |
|---|---|---|
| Income statement | ||
| Revenue | €27.3M | €22.6M |
| Cost of sales | €16.7M | €13.8M |
| Gross profit | €10.6M | €8.7M |
| Other income | €93.1K | €580.9K |
| Administrative expenses | €1.6M | €1.4M |
| Depreciation & amortisation | €6.6K | €7.0K |
| Operating profit (EBIT) | €926.5K | €438.5K |
| Net finance income / (cost) | €70.9K | €43.5K |
| Finance costs | €71.5K | €96.5K |
| Profit before tax | €855.5K | €395.0K |
| Income tax expense | €72.5K | €155.9K |
| Profit for the year | €783.0K | €239.2K |
| Total comprehensive income | €802.5K | €239.2K |
| Per share | ||
| Diluted EPS | €0.05 | €0.02 |
| Free cash flow / share | €0.12 | €0.09 |
| Cash flow statement | ||
| Cash generated from operations | €3.4M | €2.6M |
| Net cash from operating activities | €3.2M | €2.5M |
| Income taxes paid | €136.9K | €142.0K |
| Net cash from investing activities | €1.4M | €1.0M |
| Purchase of PP&E (capex) | €1.4M | €1.1M |
| Net cash from financing activities | €750.4K | €634.9K |
| Dividends paid | €339.6K | €185.3K |
| Repayments of borrowings | €57.7K | €62.3K |
| Lease liability payments | €159.9K | €156.0K |
| Balance sheet | ||
| Total assets | €21.9M | €21.9M |
| Non-current assets | €9.4M | €9.1M |
| Property, plant & equipment | €8.7M | €8.4M |
| Intangible assets & goodwill | €656.5K | €663.1K |
| Current assets | €12.6M | €12.8M |
| Inventories | €1.3M | €1.2M |
| Trade & other receivables | €1.7M | €1.5M |
| Cash & equivalents | €1.3M | €698.9K |
| Total equity | €16.4M | €16.0M |
| Non-current liabilities | €1.9M | €2.2M |
| Long-term borrowings | €122.3K | €168.9K |
| Lease liabilities (non-current) | €697.1K | €862.0K |
| Current liabilities | €3.6M | €3.7M |
| Current portion of long-term borrowings | €46.6K | €57.7K |
| Lease liabilities (current) | €164.9K | €159.9K |
| Trade & other payables | €3.1M | €2.7M |
| Deferred tax liabilities | €741.4K | €780.3K |
| Derived metrics | ||
| Free cash flow | €1.8M | €1.5M |
| Operating margin | 3.4% | 1.9% |
| Net margin | 2.9% | 1.1% |
| Return on equity | 4.8% | 1.5% |
| Cash conversion ratio | 4.12× | 10.65× |
| Capex coverage | 2.35× | 2.33× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | €42.7K | €452.5K |
| Adjustments For Decrease Increase In Trade Account Receivable | €249.2K | €126.6K |
| Adjustments For Decrease Increase In Trade and Other Receivables | €25.2K | €16.3K |
| Adjustments For Deferred Tax Expense | €19.4K | — |
| Adjustments For Gain Loss On Disposals Property Plant and Equipment | €145.0K | — |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Property Plant and Equipment | €77.7K | €776 |
| Adjustments For Income Tax Expense | €0 | €98.8K |
| Adjustments For Increase Decrease In Deferred Income Other Than Contract Liabilities | -€3.4K | -€100.9K |
| Adjustments For Increase Decrease In Trade Account Payable | €441.0K | €741.6K |
| Adjustments For Interest Expense | €48.7K | €78.9K |
| Adjustments For Interest Income | €0 | €52.4K |
| Capital Reserve | €7.1M | €6.7M |
| Cash and Cash Equivalents If Different From Statement of Financial Position | €1.1M | €19.0K |
| Cash Flows From Used In Operations Before Changes In Working Capital | €3.2M | €2.9M |
| Changes In Equity | — | €329.7K |
| Current Biological Assets | €8.1M | €9.3M |
| Current Borrowings and Current Portion of Noncurrent Borrowings | €243.5K | €717.9K |
| Current Government Grants | €70.8K | €64.4K |
| Current Tax Assets Current | €101.3K | €41.1K |
| Deferred Tax Assets | €13.4K | €28.6K |
| Depreciation Property Plant and Equipment | €1.0M | €972.8K |
| Equity and Liabilities | €21.9M | €21.9M |
| Finance Income | €525 | €53.0K |
| Gains Losses On Fair Value Adjustment Biological Assets | €1.2M | €1.3M |
| Impairment Loss Recognised In Profit Or Loss Trade Receivables | €23.5K | €16.3K |
| Increase Decrease In Cash and Cash Equivalents | €1.1M | €881.9K |
| Increase Decrease Through Other Distributions To Owners | €70.4K | €144.5K |
| Interest Paid Classified As Financing Activities | €48.7K | €78.9K |
| Interest Received Classified As Investing Activities | €0 | €52.4K |
| Issued Capital | €2.6M | €2.6M |
| Liabilities | €5.5M | €5.9M |
| Noncurrent Biological Assets | €0 | €42.9K |
| Noncurrent Government Grants | €364.7K | €374.4K |
| Other Inflows Outflows of Cash Classified As Financing Activities | €144.5K | €152.6K |
| Other Operating Income Expense | €77.7K | €147.4K |
| Proceeds From Sales of Intangible Assets Classified As Investing Activities | €1 | — |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €7.6K | €9.8K |
| Profit Loss From Continuing Operations | €783.0K | €239.2K |
| Sales and Marketing Expense | €6.8M | €6.0M |
| Share Premium | €6.8M | €6.8M |
Every line item above is a fact tagged in BLUE ISLAND PLC's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.